Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

The discovery of dabigatran etexilate.

van Ryn J, Goss A, Hauel N, Wienen W, Priepke H, Nar H, Clemens A.

Front Pharmacol. 2013 Feb 12;4:12. doi: 10.3389/fphar.2013.00012. eCollection 2013.

2.

New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Scaglione F.

Clin Pharmacokinet. 2013 Feb;52(2):69-82. doi: 10.1007/s40262-012-0030-9. Review.

PMID:
23292752
3.

Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.

Baetz BE, Spinler SA.

Pharmacotherapy. 2008 Nov;28(11):1354-73. doi: 10.1592/phco.28.11.1354. Review.

PMID:
18956996
4.

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.

Ma TK, Yan BP, Lam YY.

Pharmacol Ther. 2011 Feb;129(2):185-94. doi: 10.1016/j.pharmthera.2010.09.005. Epub 2010 Oct 12. Review.

PMID:
20920530
5.

Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.

Bovio JA, Smith SM, Gums JG.

Ann Pharmacother. 2011 May;45(5):603-14. doi: 10.1345/aph.1P644. Epub 2011 May 3. Review.

PMID:
21540406
6.

Dabigatran etexilate: A novel oral direct thrombin inhibitor.

Blommel ML, Blommel AL.

Am J Health Syst Pharm. 2011 Aug 15;68(16):1506-19. doi: 10.2146/ajhp100348. Review.

PMID:
21817082
7.

Ximelagatran: a new oral anticoagulant.

Hrebickova L, Nawarskas JJ, Anderson JR.

Heart Dis. 2003 Nov-Dec;5(6):397-408. Review.

PMID:
14633322
8.

Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation.

Salazar CA, del Aguila D, Cordova EG.

Cochrane Database Syst Rev. 2014 Mar 27;(3):CD009893. doi: 10.1002/14651858.CD009893.pub2. Review.

PMID:
24677203
9.

[New anticoagulants - direct thrombin inhibitors].

Brand B, Graf L.

Ther Umsch. 2012 Nov;69(11):643-9. doi: 10.1024/0040-5930/a000342. Review. German.

PMID:
23117667
10.

Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Eriksson BI, Dahl OE.

Drugs. 2004;64(6):577-95. Review. Erratum in: Drugs. 2004;64(8):912.

PMID:
15018589
11.

Dabigatran etexilate: future directions in anticoagulant treatment.

Schulman S, Reilly PA.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:32S-41S. doi: 10.1177/1076029609344199. Epub 2009 Aug 13. Review.

PMID:
19679590
12.

Dabigatran etexilate in atrial fibrillation.

Vora A.

J Assoc Physicians India. 2013 Dec;61(12):900-2. Review.

PMID:
24968547
13.

Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders.

Cheng JW, Vu H.

Clin Ther. 2012 Apr;34(4):766-87. doi: 10.1016/j.clinthera.2012.02.022. Epub 2012 Mar 22. Review.

PMID:
22444784
14.
15.

Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.

Stangier J, Clemens A.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:9S-16S. doi: 10.1177/1076029609343004. Epub 2009 Aug 19. Review.

PMID:
19696042
16.

Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.

Dzeshka MS, Lip GY.

Expert Opin Drug Saf. 2015 Jan;14(1):45-62. doi: 10.1517/14740338.2015.973847. Epub 2014 Oct 24. Review.

PMID:
25341529
17.

Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.

Siddiqui FM, Qureshi AI.

Expert Opin Pharmacother. 2010 Jun;11(8):1403-11. doi: 10.1517/14656566.2010.482931. Review.

PMID:
20446854
18.

Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges.

Mangiafico RA, Mangiafico M.

Curr Med Chem. 2012;19(27):4688-98. Review.

PMID:
22830344
19.

Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery.

Agnelli G, Sonaglia F, Becattini C.

Curr Pharm Des. 2005;11(30):3885-91. Review.

PMID:
16305519
20.

The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.

Mavrakanas T, Bounameaux H.

Pharmacol Ther. 2011 Apr;130(1):46-58. doi: 10.1016/j.pharmthera.2010.12.007. Epub 2010 Dec 24. Review.

PMID:
21185864

Supplemental Content

Support Center